$TMDX News

Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $75

TransMedics: Despite Earnings Miss, Growth Story Remains Intact

TransMedics Group Inc (NASDAQ:TMDX) – A Prime Example of Affordable Growth in Medical Technology

TransMedics Group, Inc. 2026 Q1 - Results - Earnings Call Presentation

If You Invested $1000 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today

TransMedics: Cheaper, But Still Priced For Perfection

Canaccord Genuity Maintains Buy on TransMedics Group, Lowers Price Target to $124

TD Cowen Maintains Buy on TransMedics Group, Lowers Price Target to $120

Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $85

Piper Sandler Maintains Overweight on TransMedics Group, Lowers Price Target to $120

Needham Maintains Buy on TransMedics Group, Lowers Price Target to $142

TransMedics Group Inc (NASDAQ:TMDX) Plunges 27% After Major Q1 Earnings Miss

TransMedics Group, Inc. (TMDX) Q1 2026 Earnings Call Transcript

TransMedics Group Affirms FY2026 Sales Guidance of $727.000M-$757.000M vs $737.825M Est

TransMedics Gr Q1 Adj. EPS $0.30 Misses $0.61 Estimate, Sales $173.933M Beat $172.636M Estimate

TransMedics Announces Definitive Agreement To Invest In PAD Aviation To Develop Dedicated Organ Transplant Air And Ground Logistics Network In Europe; Terms Not Disclosed

Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now?

TransMedics: Revolutionizing The Organ Transplant Market While Trading At A Discount

TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting

TransMedics Group To Unveil New Controlled, Active Cooling Preservation Device, Controlled Hypothermic Organ Preservation System At ISHLT 2026 Annual Meeting